A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Phase 1
- Conditions
- Colorectal CancerPancreatic Ductal CarcinomaEsophageal Squamous Cell CarcinomaBreast CancerNon-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaOther Solid Tumors
- Interventions
- First Posted Date
- 2019-08-05
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT04045496
- Locations
- 🇺🇸
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
🇺🇸HealthONE Clinic Services Oncology-Hematology, Denver, Colorado, United States
🇺🇸Tennessee Oncology, PLLC, Nashville, Tennessee, United States
A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China
Phase 1
- Conditions
- Other Metastatic Solid TumorsEsophageal CancerNon-small Cell Lung CancerHead and Neck Cancer
- Interventions
- First Posted Date
- 2018-06-21
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT03565003
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳Peking Union Medical College Hospital, Beijing, Beijing, China
🇨🇳Beijing Cancer Hospital, Beijing, Beijing, China
A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Non-small Cell Lung CancerHead and Neck CancerEsophageal CancerOther Metastatic Solid Tumors
- Interventions
- First Posted Date
- 2018-05-08
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT03518554
- Locations
- 🇺🇸
HealthONE Clinic Services Oncology-Hematology, Denver, Colorado, United States
🇺🇸Sarah Cannon Research Institute, Nashville, Tennessee, United States
🇺🇸Florida Cancer Specialists, Sarasota, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath